WASHINGTON (dpa-AFX) - Neurocrine Biosciences Inc. (NBIX) said that Kevin Gorman will retire as Chief Executive Officer of the company on October 11, 2024. Kyle Gano, currently Neurocrine's Chief ...
Some results have been hidden because they may be inaccessible to you